Elanco Animal Health Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Elanco Animal Health Inc 公司

Elanco Animal Health Incorporated 是一家动物保健公司。该公司专注于提供产品和服务，以预防和治疗农场动物和宠物的疾病。其多样化、耐用的产品组合服务于许多物种的动物，主要包括：狗、猫和牛、家禽、猪和羊。该公司提供两大类产品：宠物保健和农场动物。其宠物保健产品组合专注于杀虫剂、疫苗和治疗剂。其宠物保健产品组合包括保护宠物免受跳蚤、蜱虫和体内寄生虫侵害的产品。其农场动物产品组合主要针对牛、猪和家禽。其宠物保健产品包括 Advantage Family、Atopica、Claro/ Neptra、Credelio Family、Drontal Family、Galliprant、Interceptor Plus、Milbemax、Onsior、Seresto、Trifexis 和 TruCan。其农场动物产品包括 AviPro、Baycox、Catosal、Comforta、Denagard、Experior、Hemicell、Maxiban、Monteban、Pulmotil、Rumensin 等。

Elanco Animal Health Inc简介



公司代码ELAN

公司名称Elanco Animal Health Inc

上市日期Sep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

员工数量9000

证券类型Ordinary Share

年结日Sep 20

公司地址2500 Innovation Way N

城市GREENFIELD

上市交易所NYSE Consolidated

国家United States of America

邮编46140-9163

电话18773526261

网址https://www.elanco.com/

公司代码ELAN

上市日期Sep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

Elanco Animal Health Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

79.40K

--

Mr. Paul S. Herendeen

Independent Director

74.50K

--

Mr. James Meer

Senior Vice President, Chief Accounting Officer

62.55K

-1.82%

Ms. Shiv O'Neill

Executive Vice President, General Counsel, Corporate Secretary

53.92K

+100.82%

名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Pet Health

643.00M

51.81%

Farm Animal

583.00M

46.98%

Contract Manufacturing

15.00M

1.21%

地区USD

名称

营收

占比

International

648.00M

52.22%

United States

593.00M

47.78%

业务

地区

业务USD

名称

营收

占比

Pet Health

643.00M

51.81%

Farm Animal

583.00M

46.98%

Contract Manufacturing

15.00M

1.21%

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

Dodge & Cox

16.69%

PRIMECAP Management Company

10.42%

Fidelity Management & Research Company LLC

9.71%

The Vanguard Group, Inc.

9.59%

Dimensional Fund Advisors, L.P.

4.58%

其他

49.02%

持股股东

占比

Dodge & Cox

16.69%

PRIMECAP Management Company

10.42%

Fidelity Management & Research Company LLC

9.71%

The Vanguard Group, Inc.

9.59%

Dimensional Fund Advisors, L.P.

4.58%

其他

49.02%

股东类型

持股股东

占比

Investment Advisor

64.88%

Investment Advisor/Hedge Fund

33.32%

Hedge Fund

7.73%

Research Firm

1.86%

Individual Investor

1.11%

Pension Fund

0.98%

Bank and Trust

0.53%

Sovereign Wealth Fund

0.18%

Family Office

0.12%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

856

545.76M

109.85%

-16.85M

2025Q2

882

515.44M

103.78%

-40.64M

2025Q1

974

511.32M

102.96%

-71.50M

2024Q4

996

503.77M

101.85%

-80.73M

2024Q3

1000

494.48M

100.04%

-96.31M

2024Q2

1034

494.94M

100.16%

-92.98M

2024Q1

1051

494.01M

100.22%

-99.13M

2023Q4

1048

492.96M

100.04%

-103.67M

2023Q3

1055

493.54M

100.18%

-93.98M

2023Q2

1067

490.17M

99.54%

-75.35M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Dodge & Cox

82.90M

16.69%

-25.35K

-0.03%

Jun 30, 2025

PRIMECAP Management Company

51.77M

10.42%

+1.54M

+3.07%

Jun 30, 2025

Fidelity Management & Research Company LLC

48.24M

9.71%

+9.93M

+25.93%

Jun 30, 2025

The Vanguard Group, Inc.

47.65M

9.59%

-496.16K

-1.03%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

22.75M

4.58%

+2.28M

+11.15%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

19.58M

3.94%

-484.75K

-2.42%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

19.55M

3.94%

+3.57M

+22.35%

Jun 30, 2025

Black Creek Investment Management, Inc.

19.25M

3.87%

-2.79M

-12.67%

Jun 30, 2025

Fidelity Institutional Asset Management

16.64M

3.35%

+1.09M

+7.01%

Jun 30, 2025

Citadel Advisors LLC

13.70M

2.76%

+6.83M

+99.53%

Jun 30, 2025

持股ETF



更新时间: 11月2日周日

机构名称

占比

iShares U.S. Pharmaceuticals ETF

3.69%

First Trust Health Care Alphadex Fund

2.98%

Brandes US Small-Mid Cap Value ETF

2.88%

SPDR S&P Pharmaceuticals ETF

2.64%

VanEck Agribusiness ETF

2.01%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.98%

Invesco S&P MidCap 400 Pure Value ETF

1.14%

First Trust NASDAQ Pharmaceuticals ETF

1.14%

Pacer US Export Leaders ETF

1.1%

Federated Hermes MDT Large Cap Value ETF

1.05%

iShares U.S. Pharmaceuticals ETF

占比3.69%

First Trust Health Care Alphadex Fund

占比2.98%

Brandes US Small-Mid Cap Value ETF

占比2.88%

SPDR S&P Pharmaceuticals ETF

占比2.64%

VanEck Agribusiness ETF

占比2.01%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

占比1.98%

Invesco S&P MidCap 400 Pure Value ETF

占比1.14%

First Trust NASDAQ Pharmaceuticals ETF

占比1.14%

Pacer US Export Leaders ETF

占比1.1%

Federated Hermes MDT Large Cap Value ETF

占比1.05%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据